Robert Andrew Douglas - Nov 11, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO ResMed Inc.
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Stock symbol
RMD
Transactions as of
Nov 11, 2021
Transactions value $
-$1,953,279
Form type
4
Date filed
11/15/2021, 07:44 PM
Previous filing
Oct 18, 2021
Next filing
Nov 18, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability -$245K -945 -4.25% $259.47 21.3K Nov 11, 2021 Direct F1, F2
transaction RMD ResMed Common Stock Options Exercise $466K +8K +37.62% $58.24 29.3K Nov 15, 2021 Direct F3
transaction RMD ResMed Common Stock Sale -$2.17M -8K -27.34% $271.75 21.3K Nov 15, 2021 Direct F3
holding RMD ResMed Common Stock 210K Nov 11, 2021 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -8K -7.84% $0.00 94.1K Nov 15, 2021 ResMed Common Stock 8K $58.24 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/19/2020.
F2 Includes 62.8289 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.
F3 The transaction was conducted under a Rule 10b5-1 plan.
F4 Represents date options first became exercisable. Options vest 1/3 per year.